Conatus Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Conatus Pharmaceuticals's estimated annual revenue is currently $4.8M per year. 0
- Conatus Pharmaceuticals's total funding is $62.1M.
Employee Data
- 00
Conatus Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|
Conatus Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Conatus Pharmaceuticals?
Conatus Pharmaceuticals was founded by the executive management team of Idun Pharmaceuticals in July 2005 following the successful sale of Idun to Pfizer. At Idun, the Conatus team pioneered the science of apoptosis and the clinical development of pan caspase inhibitors, validating this first-in-class technology. Conatus has well established relationships with key opinion leaders in the fields of hepatology, infectious disease and inflammation. The Conatus team has over 80 years of experience in the pharmaceutical industry and has created multiple successful partnerships with global pharmaceutical companies. The Conatus team has an excellent track record with blue chip investors that are active in financing successful biotechnology companies.
keywords:N/A
$62.1M
Total Funding
N/A
Number of Employees
$4.8M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Conatus Pharmaceuticals News
Conatus Pharmaceuticals Inc; Pharmedartis Gmbh Caspase 9 Market Breakdown by Type: Emricasan; Flavokawain A; Mbri-001; Plinabulin; Other.
Conatus Pharmaceuticals Inc Digna Biotech S.J. Dompe Pharmaceutical S.p. A Thompson Surgical Integra Life Sciences AbbVie Inc
... the YMCA of San Diego County and Corporate Directors Forum, and previously served as a member of the board of Conatus Pharmaceuticals.
Conatus Pharmaceuticals Inc... Take 1 minute to subscribe and you'll get this story immediately, plus: Already a subscriber? Sign in 52 weekly issues Subscriber-only digital content every business day, plus full access to SDBJ.com archives Book of Lists — the most comprehensive business resou ...
Conatus Pharmaceuticals Inc., a San Diego, CA-based biopharmaceutical company engaged in the development of innovative human therapeutics to treat liver disease and oncology, has received an additional $7.5m investment by MPM Capital, closing its Series B round at $32.5m. The first closing was ...
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $18M | 0 | N/A | $168.6M |
#2 | $8.4M | 0 | N/A | N/A |
#3 | $11.7M | 0 | N/A | $4.4M |
#4 | $36.4M | 0 | N/A | $778M |
#5 | $1.7M | 0 | N/A | N/A |